Workflow
*ST广道
icon
Search documents
新股发行及今日交易提示-20251205
HWABAO SECURITIES· 2025-12-05 09:44
New Stock Issuance - New stocks issued include Angrui Micro (787790) at a price of 83.06 and Muxi Co., Ltd. (787802) at 104.66[1] - The new stock listing for Moer Thread (688795) is also noted, although the issuance price is not specified[1] Rights Issues and Announcements - The rights offering period for Chuan Yin Gao Ke (300087) is from December 4, 2025, to January 5, 2026[1] - Tianpu Co., Ltd. (605255) has a rights offering period from November 20, 2025, to December 19, 2025[1] Delisting and Abnormal Fluctuations - *ST Guangdao (920680) will enter the delisting arrangement period starting December 11, 2025[1] - *ST Suwu (600200) will enter the delisting arrangement period starting December 9, 2025[1] - Severe abnormal fluctuations were reported for Saiwei Electronics (300456) and Beida Pharmaceutical (000788)[1] Additional Announcements - Multiple companies, including Huaitian Thermal Power (000692) and Junya Technology (603386), have recent announcements regarding their stock performance[1] - The report includes links to detailed announcements for various companies, indicating ongoing market activity and regulatory compliance[1]
*ST广道:12月11日进入退市整理期
Mei Ri Jing Ji Xin Wen· 2025-12-03 15:45
Group 1 - The company *ST Guangdao announced that it will not appeal the decision for mandatory delisting from the Beijing Stock Exchange [2] - The stock will enter a delisting preparation period starting December 11, with the last trading day expected to be December 31 [2] - After the delisting preparation period, the stock will be officially removed from the exchange [2]
新股发行及今日交易提示-20251127
HWABAO SECURITIES· 2025-11-27 09:47
New Stock Listings - Nant Technology (920124) listed at an issue price of 8.66 on November 27, 2025[1] - Tianpu Co., Ltd. (605255) is in the offer period from November 20 to December 19, 2025[1] - Jianglong Shipbuilding (300589) and Huasheng Lithium Battery (688353) reported significant abnormal fluctuations[1] Abnormal Fluctuations - Multiple companies including ST Wanfang (000638) and ST Dongyi (002713) have reported abnormal trading activities[2] - Companies such as ST Suwu (600200) and ST Yanshan (000608) are also under scrutiny for unusual market behavior[3]
五连板实达集团:网络传闻公司与阿里云合作不实;*ST广道将终止上市|公告精选
Mei Ri Jing Ji Xin Wen· 2025-11-26 16:09
Mergers and Acquisitions - Aladdin plans to acquire 35% equity of Youke for a cash consideration of 61.25 million yuan [1] - Huafeng Aluminum intends to acquire 100% equity of Huafeng Puen for a cash amount of 100 million yuan [2] Shareholding Changes - New锐股份 announces that its major shareholder plans to reduce its stake by up to 0.50%, equating to a maximum of 1.2622 million shares [3] - 微芯生物 reports that 博奥生物 has completed a share reduction of 3%, totaling 12.2339 million shares [4] - *ST宝实's controlling shareholder plans to increase its stake in the company, with an investment ranging from 21 million to 42 million yuan [5] Risk Matters - *ST广道's stock is set to be delisted following a decision from the exchange, with a potential review application period of 15 trading days [6] - 天下秀 announces a tax payment and penalty of approximately 24.5157 million yuan, which is expected to reduce its 2025 net profit by about 23.8413 million yuan, representing 46.30% of the latest audited net profit [7] - ST泉为's subsidiary is involved in a significant lawsuit with a claim amounting to 32.7616 million yuan, with uncertain impacts on future profits [8] Market Rumors - 实达集团 clarifies that rumors regarding a partnership with Alibaba Cloud are untrue, and the acquisition of a 95% stake in Fujian Shuchan Ming Shang Technology remains uncertain [9]
11月26日这些公告有看头
Di Yi Cai Jing Zi Xun· 2025-11-26 13:44
Major Announcements - Zhejiang Pharmaceutical plans to spin off its subsidiary Zhejiang Xima Biopharmaceutical Co., Ltd. for a listing on the Hong Kong Stock Exchange to enhance its drug biopharmaceutical segment and overall profitability [3] - Meiyang Jixiang's subsidiary has received acceptance for a mineral resource reserve review application from the Ministry of Natural Resources [4] - Shida Group denies rumors of a partnership with Alibaba Cloud, stating that no business cooperation has been initiated [5] - ST Quanwei's subsidiary is involved in a significant lawsuit amounting to RMB 32.76 million [6] - Yidong Electronics intends to invest RMB 61.2 million to acquire a 51% stake in Shenzhen Guanding Metal Technology Co., Ltd. to expand into AI server cooling products [7] - ST Lian Stone's stock will be suspended on November 27, 2025, due to a capital increase plan approved by the court [8] - ST Guangdao's stock is set to be delisted following a decision from the Beijing Stock Exchange [9] - CICC is planning a major asset restructuring, leading to a suspension of its stock for up to 25 trading days [10] - Aolai De plans to raise up to RMB 300 million through a private placement for an OLED core material production project [11] - Jindike announces no new approvals for quadrivalent influenza virus vaccines for the remainder of the year [12] Financial Performance - Li Auto reported a third-quarter revenue of RMB 27.4 billion, down from RMB 42.87 billion year-on-year, with an operating loss of RMB 1.2 billion compared to a profit of RMB 3.4 billion in the same quarter last year [13] Shareholding Changes - ST Baoshi's major shareholder plans to increase its stake by up to 0.66% within six months [14] - Debang Technology's major shareholder has reduced its stake by 2% from September 11 to October 16 [15][16] - New Rui shares' shareholder intends to reduce its stake by up to 0.50% from December 18, 2025, to March 17, 2026 [17] Major Contracts - Guangdian Yuntong has won a bid for an artificial intelligence application pilot base construction project worth RMB 308 million [18]
11月26日这些公告有看头
第一财经· 2025-11-26 13:04
Major Announcements - Zhejiang Pharmaceutical plans to spin off its subsidiary Zhejiang Xima Biopharmaceutical Co., Ltd. for a listing on the Hong Kong Stock Exchange to enhance its drug biopharmaceutical segment and overall profitability [4] - Meiyang Jixiang's subsidiary has received acceptance for its mineral resource reserve review application from the Ministry of Natural Resources [5] - Shida Group's stock price has deviated significantly, with a cumulative increase of over 40% in four consecutive trading days, while the company reported a revenue of 134.59 million yuan and a net loss of 87.57 million yuan for the third quarter [6] - ST Quanwei's subsidiary is involved in a significant lawsuit amounting to 32.76 million yuan, with uncertain impacts on future profits [7] - Yidong Electronics plans to invest 61.2 million yuan to acquire a 51% stake in Shenzhen Guanding Metal Technology Co., Ltd. to expand into AI server cooling products [8] - ST Lian Stone's stock will be suspended on November 27, 2025, due to a capital increase plan approved by the court [9] - ST Guangdao's stock will be delisted following a decision from the Beijing Stock Exchange [10] - Zhongjin Company is planning a major asset restructuring and has suspended its stock trading [11][12] - Aolaide intends to raise up to 300 million yuan through a private placement for its OLED core material production project [13] - Jindike announced it will not issue new batches of quadrivalent influenza virus vaccines this year, with 1.56 million doses already certified [14] Performance Insights - Li Auto reported a third-quarter revenue of 27.4 billion yuan, down from 42.87 billion yuan year-on-year, with an operating loss of 1.2 billion yuan [15] Shareholding Changes - ST Baoshi's major shareholder plans to increase its stake by up to 0.66% [16] - Debang Technology's major shareholder has reduced its stake by 2% [17][18] - New Rui shares announced a planned reduction of up to 0.50% by a major shareholder [19] Major Contracts - Guangdian Yuntong has won a bid for an artificial intelligence application pilot base construction project worth 308 million yuan [20]
晚间公告|11月26日这些公告有看头
Di Yi Cai Jing· 2025-11-26 10:17
Core Viewpoint - Zhejiang Medicine plans to spin off its subsidiary Zhejiang Xima Biopharmaceutical Co., Ltd. for a listing on the Hong Kong Stock Exchange to enhance its biopharmaceutical segment and overall profitability [2] Company Announcements - Zhejiang Medicine is in the early planning stages for the spin-off, with no specific plan finalized yet, indicating uncertainty [2] - Meiyang Jixiang's subsidiary has received acceptance for a mineral resource reserve review application from the Ministry of Natural Resources [3] - Shida Group refutes rumors of a partnership with Alibaba Cloud, highlighting a significant stock price increase and ongoing losses [4] - ST Quanwei's subsidiary is involved in a major lawsuit amounting to RMB 32.76 million, with uncertain impacts on profits [5] - Yidong Electronics plans to invest RMB 61.2 million to acquire 51% of Shenzhen Guanding Metal Technology Co., Ltd. to expand into AI server cooling products [6] - ST Lian Stone's stock will be suspended on November 27 due to a capital increase plan approved by the court [7] - ST Guangdao's stock is set to be delisted following a decision from the Beijing Stock Exchange [8] - CICC is planning a major asset restructuring, leading to a temporary suspension of its stock [9] - Aolaide intends to raise up to RMB 300 million through a private placement for an OLED materials production project [10] - Jindike announces no new approvals for quadrivalent influenza virus vaccines this year, with sales affected by seasonal demand [11] Performance Reports - Li Auto reported a third-quarter revenue of RMB 27.4 billion, down from RMB 42.87 billion year-on-year, with a loss of RMB 1.2 billion compared to a profit of RMB 3.4 billion in the same quarter last year [13] Shareholding Changes - ST Baoshi's major shareholder plans to increase its stake by up to 0.66%, with a minimum investment of RMB 21 million [15] - Debang Technology's major shareholder has reduced its stake by 2% through various trading methods [16] - New Rui Co. plans to reduce its stake by up to 0.50% due to funding needs [18] Major Contracts - Guangdian Yuntong has won contracts totaling RMB 308 million for the construction of an artificial intelligence application pilot base [20]
皮海洲:对北交所首单退市事件的几点思考 | 立方大家谈
Sou Hu Cai Jing· 2025-11-25 02:30
Core Viewpoint - The delisting of *ST Guandao marks a significant event as it becomes the first company to be delisted from the Beijing Stock Exchange, highlighting concerns about the quality of listed companies in a relatively new market [1][3]. Group 1: Delisting Process - *ST Guandao has received a formal notice from the Beijing Stock Exchange regarding the termination of its stock listing, with a 15-day window for the company to appeal the decision [1]. - Following the delisting, the company's shares will transition to the national stock transfer system, where they will be managed under specific regulations [1]. Group 2: Financial Fraud - The company has been involved in financial fraud for seven consecutive years, inflating revenue and costs through fabricated documents, leading to significant discrepancies in reported figures [2]. - From 2018 to the first half of 2024, *ST Guandao inflated its reported revenue by amounts ranging from approximately 142.97 million yuan to 303.97 million yuan, with the inflated figures constituting up to 99.39% of the reported amounts in certain years [2]. - The inflated costs during the same period ranged from approximately 64.65 million yuan to 162.51 million yuan, also representing a significant percentage of the reported figures [2]. Group 3: Regulatory Actions - The China Securities Regulatory Commission (CSRC) issued an administrative penalty against *ST Guandao on September 12, 2025, resulting in lifetime bans for the chairman and financial officer from the securities market [3]. - The delisting decision by the Beijing Stock Exchange is a direct consequence of the CSRC's findings regarding the company's financial misconduct [3]. Group 4: Market Implications - The delisting of *ST Guandao raises questions about the vetting process for companies entering the Beijing Stock Exchange, particularly regarding the oversight of companies with a history of financial misconduct [4]. - The involvement of accounting firms in the fraud raises concerns about their responsibilities and potential negligence in detecting the fraudulent activities over the years [4]. Group 5: Compensation Initiatives - The underwriting institution, Wukuang Securities, has proposed to establish a compensation fund of approximately 220 million yuan to address the investment losses suffered by affected investors due to the company's violations [5]. - While the initiative to compensate investors is commendable, it should not absolve the underwriting institution or responsible parties from accountability for their roles in the situation [5].
11月24日盘前停复牌汇总
Group 1 - Three companies have been temporarily suspended from trading: Chaozhuo Hangke, Kaizhong Co., and Jiahua Technology [1][2] - Chaozhuo Hangke (688237.SH) is suspended for one day to announce important information [2] - Kaizhong Co. (603037.SH) is suspended for one day as it plans to reorganize significant assets [2] - Jiahua Technology (688051.SH) is suspended for one day to plan a major asset restructuring [2] Group 2 - Nine companies continue to be suspended from trading, including *ST Yuancheng, *ST Guangdao, and *ST IE Ping, due to various reasons such as publishing important announcements and abnormal trading fluctuations [2] - Dongxing Securities (601198.SH) is suspended as it plans to reorganize significant assets [2] - Other companies like Xinda Securities (601059.SH) and Zhongjin Company (601995.SH) are also suspended for similar reasons related to major asset restructuring [2]
年内15股停牌核查,过半系风险警示股
Core Viewpoint - The A-share market has seen a significant number of stocks undergoing suspension for verification, with 15 stocks suspended this year, and a notable portion of these stocks are under risk warning due to poor financial performance [1][4]. Group 1: Suspension and Verification - A total of 15 stocks have been suspended for verification this year, with *ST Zhengping undergoing its third suspension on November 19 [2][3]. - Among the 15 suspended stocks, 8 are risk warning stocks, accounting for over 53% of the total [4]. - *ST Zhengping has experienced a substantial increase in its stock price, achieving a cumulative increase of 221.93% over 36 trading days prior to the latest suspension [2]. Group 2: Financial Performance - Of the 14 stocks that have disclosed their financial results, 11 reported net losses in the first three quarters of 2025, representing approximately 78.57% of the group [4][6]. - *ST Guandao is unable to disclose its third-quarter report within the legal timeframe, highlighting the financial distress among these companies [4]. - The largest net loss among the disclosed stocks was reported by ST Zhongdi, with a net profit of approximately -151 million yuan [5]. Group 3: Market Trends - In the period from November 3 to November 19, several stocks, excluding the 15 suspended ones, saw significant price increases, with Huasheng Lithium achieving a cumulative increase of 138.49% [7]. - The market is experiencing a trend where stocks with high volatility and speculative trading are prevalent, raising concerns about the sustainability of such price movements [8].